Clinical Trial Update: Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating an autologous total IgG immunotherapy administered intramuscularly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunotherapy

Drugs mentioned

• Autologous total IgG immunotherapy (proposed)

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Immunotherapy | Phase 1, Phase 2 | Status: COMPLETED